Information Links
Mims
Main Navigation
Drugs
Conditions
Articles 
MIMS Dermatology Clinic
Latest news and quick-reference resources collated by the MIMS editors to support primary care prescribing for dermatological conditions, including eczema, psoriasis and acne.
Latest news
NICE approves guselkumab for plaque psoriasis
Guselkumab (Tremfya) is now an option for routine NHS...
Emollient bath additives 'no benefit' in childhood eczema
Emollient bath additives provide no clinical benefit...
Psoriasis biologic approved for NHS prescribing
Brodalumab (Kyntheum) can now be prescribed routinely...
Dupilumab: first biologic for moderate-to-severe atopic dermatitis
Dupilumab (Dupixent) is the first biologic treatment...
Guselkumab further extends choice in psoriasis prescribing
Tremfya (guselkumab) is licensed for the treatment...
At-a-glance product comparison charts.
Drug assessments by NICE.
-
Ixekizumab for Treating Moderate to Severe Plaque Psoriasis (TA442)
-
Apremilast for Treating Moderate to Severe Plaque Psoriasis (TA419)
-
Nivolumab in Combination with Ipilimumab for Treating Advanced Melanoma (TA400)
-
Trametinib in Combination with Dabrafenib for Treating Unresectable or Metastatic Melanoma (TA396)
-
Adalimumab for Treating Moderate to Severe Hidradenitis Suppurativa (TA392)
From our sister sites
Articles from 
CPD from 
Dermatology presentations package - 7 key topics
Calculators
External resources
Useful websites and online tools to support prescribing for skin conditions.